Recent Progress and Advances in HGF/MET-Targeted Therapeutic Agents for Cancer Treatment

The hepatocyte growth factor (HGF): MET axis is a ligand-mediated receptor tyrosine kinase pathway that is involved in multiple cellular functions, including proliferation, survival, motility, and morphogenesis. Aberrancy in the HGF/MET pathway has been reported in multiple tumor types and is associ...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yilong, Jain, Rajul K., Zhu, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344234/
https://www.ncbi.nlm.nih.gov/pubmed/28536405
http://dx.doi.org/10.3390/biomedicines3010149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344234/
https://www.ncbi.nlm.nih.gov/pubmed/28536405
http://dx.doi.org/10.3390/biomedicines3010149

Ejemplares similares